River Wealth Advisors LLC boosted its stake in Stryker Corporation (NYSE:SYK) by 1.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 28,422 shares of the medical technology company’s stock after purchasing an additional 449 shares during the quarter. Stryker Corporation comprises about 1.8% of River Wealth Advisors LLC’s holdings, making the stock its 7th biggest position. River Wealth Advisors LLC’s holdings in Stryker Corporation were worth $4,037,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently bought and sold shares of the company. Acrospire Investment Management LLC acquired a new stake in Stryker Corporation in the second quarter worth $111,000. Bollard Group LLC grew its holdings in Stryker Corporation by 0.4% in the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 3 shares during the period. Motco grew its holdings in Stryker Corporation by 50.7% in the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 278 shares during the period. Bruderman Asset Management LLC acquired a new stake in Stryker Corporation in the second quarter worth $150,000. Finally, James Investment Research Inc. acquired a new stake in Stryker Corporation in the second quarter worth $155,000. Institutional investors and hedge funds own 74.15% of the company’s stock.
A number of equities research analysts have commented on the stock. Zacks Investment Research cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a report on Thursday, August 17th. ValuEngine upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating in a report on Tuesday. BidaskClub upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Cowen and Company restated a “buy” rating and issued a $160.00 price target (up from $150.00) on shares of Stryker Corporation in a report on Sunday, July 30th. Finally, Oppenheimer Holdings, Inc. set a $148.00 price target on shares of Stryker Corporation and gave the stock a “hold” rating in a report on Friday, July 28th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $151.52.
In related news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the transaction, the insider now owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 7.40% of the stock is currently owned by insiders.
Stryker Corporation (NYSE SYK) traded up $1.27 on Tuesday, hitting $155.75. 910,400 shares of the stock traded hands, compared to its average volume of 1,182,308. The stock has a market capitalization of $57,812.22, a P/E ratio of 24.48, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.37 and a quick ratio of 1.61. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $160.62.
Stryker Corporation (NYSE:SYK) last posted its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.50 by $0.02. The firm had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.97 billion. Stryker Corporation had a net margin of 14.67% and a return on equity of 24.11%. The company’s revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the company earned $1.39 earnings per share. research analysts expect that Stryker Corporation will post 6.47 earnings per share for the current year.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.